Presentations highlight how real-world data accelerate research and improve hematology care

The ASH Research Collaborative (ASH RC), a non-profit organization established by the American Society of Hematology (ASH) to improve the lives of those affected by blood diseases, will present new data at the 66th ASH Annual Meeting and Exposition that feature findings from its multiple myeloma and sickle cell disease research networks.

“The ASH RC has brought the multiple myeloma and sickle cell disease communities together to generate real-world evidence for researchers across the spectrum of both diseases,” said Mark Crowther, MD, MSc, chair of the ASH RC board of directors and chair of the Department of Medicine at McMaster University. “We’re thrilled to showcase our first abstracts at ASH and the research we’re presenting is just the beginning of much more to come.”

The six abstracts and special session will discuss how collaborative data sharing and real-world data support clinical outcomes in sickle cell disease and multiple myeloma, including how the SCD Learning Community informed the development of pain plans; COVID-19 outcomes in patients with multiple myeloma; the use of disease-modifying therapies in sickle cell disease; and more.

The presentations include:

About the ASH Research Collaborative

The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate research and improve outcomes for individuals with hematologic diseases by advancing treatment developments and generating evidence to support clinical decisions and care.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241202429646/en/

The @ASHCollab is presenting new data from its multiple myeloma and sickle cell disease research networks at #ASH24.